Eye on FDA
A series focused on important FDA and related regulatory developments critical to the life sciences industry.
Filter by Category
Search Results
Eye on FDA
On September 30, 2025, the Food and Drug Administration (FDA) published a Request for Public Comment to obtain feedback from interested parties on current approaches to measuring and evaluating the performance of AI-enabled medical devices. Specifically, FDA is seeking feedback on best practices, methodologies and approaches for measuring and evaluating real-world performance of AI-enabled medical devices from the public.